T&R Biofab Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
86
- Stock Symbol
-
246710
- Investments
-
2
- Share Price
-
$1.38
- (As of Thursday Closing)
T&R Biofab General Information
Description
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.
Contact Information
Website
www.tnrbiofab.comCorporate Office
- 96, Mayu-ro
- Siheung, Gyeonggi
- South Korea
Corporate Office
- 96, Mayu-ro
- Siheung, Gyeonggi
- South Korea
T&R Biofab Timeline
T&R Biofab Stock Performance
As of 12-Nov-2026, T&R Biofab’s stock price is $1.38. Its current market cap is $65.7M with 47.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.38 | $1.35 | $0.77 - $3.33 | $65.7M | 47.6M | 170K | -$0.56 |
T&R Biofab Financials Summary
As of 30-Jun-2026, T&R Biofab has a trailing 12-month revenue of $22.6M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 78,388 | 110,642 | 74,203 | 140,282 |
| Revenue | 22,554 | 18,949 | 3,572 | 3,977 |
| EBITDA | (12,452) | (14,837) | (2,515) | (9,894) |
| Net Income | (19,095) | (22,451) | (5,628) | (10,263) |
| Total Assets | 60,113 | 64,384 | 66,840 | 77,456 |
| Total Debt | 19,785 | 20,529 | 30,007 | 35,712 |
T&R Biofab Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
T&R Biofab Patents
T&R Biofab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026182320-A1 | Method for manufacturing semipermeable absorbent mesh using decellularized natural polymer | Pending | 25-Feb-2025 | ||
| WO-2026071301-A1 | Absorbable composite hemostatic agent for internal use and manufacturing method therefor | Pending | 30-Sep-2024 | ||
| WO-2026071302-A1 | Absorbable internal hemostasis kit and absorbable internal hemostatic agent | Pending | 30-Sep-2024 | ||
| EP-4556556-A1 | Method for purification and production of ventricular cardiomyocytes | Pending | 21-Sep-2023 | ||
| EP-4556556-A4 | Method for purification and production of ventricular cardiomyocytes | Pending | 21-Sep-2023 | C12N5/0657 |
T&R Biofab Signals
T&R Biofab Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
T&R Biofab Investments & Acquisitions (2)
T&R Biofab’s most recent deal was a Merger/Acquisition with Blisspack. The deal was made on 23-Apr-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Blisspack | 23-Apr-2024 | Merger/Acquisition | Plastic Containers and Packaging | ||
| Mi-face (Land and Buildings in Siheung, South Korea) | 14-Oct-2021 | Corporate Asset Purchase | Buildings and Property |
T&R Biofab ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
T&R Biofab Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Blisspack | Siheung Si, South Korea | 2002 |
T&R Biofab FAQs
-
When was T&R Biofab founded?
T&R Biofab was founded in 2013.
-
Where is T&R Biofab headquartered?
T&R Biofab is headquartered in Siheung, South Korea.
-
What is the size of T&R Biofab?
T&R Biofab has 86 total employees.
-
What industry is T&R Biofab in?
T&R Biofab’s primary industry is Other Devices and Supplies.
-
Is T&R Biofab a private or public company?
T&R Biofab is a Public company.
-
What is T&R Biofab’s stock symbol?
The ticker symbol for T&R Biofab is 246710.
-
What is the current stock price of T&R Biofab?
As of 12-Nov-2026 the stock price of T&R Biofab is $1.38.
-
What is the current market cap of T&R Biofab?
The current market capitalization of T&R Biofab is $65.7M.
-
What is T&R Biofab’s current revenue?
The trailing twelve month revenue for T&R Biofab is $22.6M.
-
What is T&R Biofab’s annual earnings per share (EPS)?
T&R Biofab’s EPS for 12 months was -$0.56.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process